Chen Yingxi, Furuya-Kanamori Luis, Doi Suhail A, Ananthakrishnan Ashwin N, Kirk Martyn
*Research School of Population Health, Australian National University, Canberra, Australia; †College of Medicine, Qatar University, Doha, Qatar; ‡School of Agricultural, Computational, and Environmental Sciences, University of Southern Queensland, Toowoomba, Australia; and §Division of Gastroenterology, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts.
Inflamm Bowel Dis. 2017 Feb;23(2):200-207. doi: 10.1097/MIB.0000000000000998.
Clostridium difficile infection (CDI) is a common complication of inflammatory bowel diseases (IBDs) and is associated with worse outcome. Variable rates of colectomy have been reported among IBD complicated by CDI. We conducted a systematic review and meta-analysis of studies to assess the association between CDI and colectomy among patients with IBD.
The literature was systematically searched using PubMed from inception through April 2016. Studies were limited to cohort, case-control, and cross-sectional studies reporting colectomy risk stratified by CDI in patients with IBD. We estimated summary ORs and 95% CIs using the quality-effects model. Study quality was assessed using an adaptation of the Newcastle-Ottawa scale.
Six studies were included in the meta-analysis, comprising 8 data sets. Results from meta-analysis showed that CDI was a significant risk factor for colectomy among patients with IBD, mainly patients with ulcerative colitis, almost doubling the odds (OR 1.90; 95% CI, 1.23-2.93). There was significant heterogeneity across studies (Q = 22.02, P < 0.001; I = 68%). Funnel plots were grossly asymmetrical. Results of sensitivity analysis restricting studies to those reporting ulcerative colitis only and studies using laboratory tests to confirm CDI were consistent with the result from the main analysis.
CDI is a significant risk factor for colectomy in patients with IBD. Further research is needed to investigate the attributable risks of surgery due to CDI among patients with Crohn's disease.
艰难梭菌感染(CDI)是炎症性肠病(IBD)的常见并发症,且与更差的预后相关。IBD合并CDI的患者中,结肠切除术的发生率各不相同。我们对相关研究进行了系统评价和荟萃分析,以评估IBD患者中CDI与结肠切除术之间的关联。
使用PubMed对从创刊至2016年4月的文献进行系统检索。研究限于队列研究、病例对照研究和横断面研究,这些研究报告了IBD患者中按CDI分层的结肠切除术风险。我们使用质量效应模型估计汇总OR值和95%CI。采用纽卡斯尔-渥太华量表的改编版评估研究质量。
荟萃分析纳入了6项研究,包含8个数据集。荟萃分析结果显示,CDI是IBD患者(主要是溃疡性结肠炎患者)结肠切除术的显著危险因素,使Odds几乎翻倍(OR 1.90;95%CI,1.23 - 2.93)。各研究间存在显著异质性(Q = 22.02,P < 0.001;I² = 68%)。漏斗图严重不对称。将研究仅限于仅报告溃疡性结肠炎的研究以及使用实验室检查确诊CDI的研究的敏感性分析结果与主要分析结果一致。
CDI是IBD患者结肠切除术的显著危险因素。需要进一步研究以调查克罗恩病患者中因CDI导致手术的归因风险。